All relevant data are within the paper and its Supporting Information files.

Background {#sec001}
==========

Genome-wide associational study (GWAS) has become a powerful genomics tool for mapping genetic loci associated with common diseases and quantitative traits. Haematological traits are important in the sense that they can reflect the immune status and healthy conditions and be utilized as biomarkers in human and animals \[[@pone.0159212.ref001]\]. Pigs are valuable as agricultural commodities and share some similarities in physiology and genome as well as haematological traits with humans. Therefore pigs can serve as a tractable model to study genetic determination of physiological and metabolic traits \[[@pone.0159212.ref002], [@pone.0159212.ref003]\].

Haematological traits include three components, leukocytes, erythrocytes and platelets, which are markers of immune and/or inflammatory responses \[[@pone.0159212.ref004], [@pone.0159212.ref005]\]. A few studies have reported on QTL mapping and GWAS for haematological traits in the pig and most studies used F2 resource populations created by mating two genetically distinct breeds \[[@pone.0159212.ref006]--[@pone.0159212.ref009]\]. Two studies of purebred pigs are available, one has detected QTL affecting haematological traits based on a linkage analysis using 206 microsatellite markers \[[@pone.0159212.ref010]\] and the other identified SNPs associated with haematological traits by GWAS \[[@pone.0159212.ref011]\]. GWAS results for haematological traits at three growth stages in a White Duroc X Erhualian F2 intercross were also reported \[[@pone.0159212.ref012]\].

In the present study, we report GWAS for haematological traits of 591 performance-tested pigs from commercial herds of German Landrace (DL) using the PorcineSNP60 BeadChip (Illumina Inc., San Diego, CA, USA). The Bayesian multi-marker approach was integrated with single-marker regression analyses to identify genomic regions and corresponding genes overlapping for both methods.

Materials and Methods {#sec002}
=====================

Animals and sample collection {#sec003}
-----------------------------

Animal care and tissue collection procedures followed the guidelines of the German Law of Animal Protection, and the experimental protocol was approved by the Animal Care Committee of the Leibniz Institute for Farm Animal Biology (FBN). Animals (n = 591) of a German Landrace (DL) herdbook herd were kept at the Experimental Farm of the FBN. Animals were fed ad libitum. Samples were collected from the pigs at an average age of 170 days at the experimental slaughter facility of the FBN after electronarcosis followed by exsanguination. Veterinary inspection of the animals before and of carcasses and organs after slaughter ensured that only animals without any impairment, disease symptoms or inflammatory and pathological signs were considered, thus avoiding any bias of blood phenotypes. Haematological traits (White blood cell count, WBC; Lymphocytes count, LYM; Red blood cell count, RBC; Haemoglobin concentration, HGB; Haematocrit level, HCT; Mean Corpuscular Volume, MCV; Mean Corpuscular Haemoglobin, MCH; Mean Corpuscular Haemoglobin Concentration, MCHC; Red Distribution Width, RDW; Platelets, PLT; Mean Platelet Volume, MPV; Plateletcrit, PCT; [Table 1](#pone.0159212.t001){ref-type="table"}) were determined using an automated blood analyser device (ABX Pentra 60 HORIBA, Montpellier, France). Liver tissues were sampled in order to extract DNA using the QIAamp DNA Mini Kit (Qiagen, Hilden, Germany).

10.1371/journal.pone.0159212.t001

###### Number of samples, means, standard deviations, variance components and estimates of heritability for haematological traits.

![](pone.0159212.t001){#pone.0159212.t001g}

  Traits            N     Mean ± SD      σ^2^~e~   σ^2^~a~   h^2^
  ----------------- ----- -------------- --------- --------- ------
  WBC (10³/mm³)     558   20.8 ± 4.9     17.98     5.33      0.23
  LYM (\#)          567   7.6 ± 1.9      1.66      1.57      0.49
  RBC (10^6^/mm³)   567   8.1 ± 0.8      0.39      0.27      0.41
  HGB (g/dl)        559   13.7 ± 1.4     1.21      0.80      0.40
  HCT (%)           564   43.2 ± 3.9     9.53      4.92      0.34
  MCV (μm³)         567   53.4 ± 3.3     3.29      7.22      0.69
  MCH(pg)           561   16.9 ± 1.3     0.56      1.12      0.67
  MCHC (g/dl)       561   31.7 ± 1.2     0.45      0.90      0.67
  RDW (%)           565   16.5 ± 1.9     1.70      1.59      0.48
  PLT (10³/mm³)     545   317.5 ± 82.2   4016.67   2522.7    0.39
  MPV (μm³)         564   7.5 ± 0.5      0.19      0.11      0.37
  PCT(%)            555   0.2 ± 0.1      0.02      0.004     0.17

WBC, White blood cell count; LYM (\#), Lymphocytes count, RBC, Red blood cell count; HGB, Haemoglobin concentration; HCT, Haematocrit level; MCV, Mean Corpuscular Volume; MCH, Mean Corpuscular Haemoglobin; MCHC, Mean Corpuscular Haemoglobin Concentration; RDW, Red Distribution Width; PLT, Platelets; MPV, Mean Platelet Volume; PCT, Plateletcrit;. σ2~e~, residual variance; σ2~a~, additive genetic variance; h^2^, heritability.

SNP genotypes {#sec004}
-------------

Genotyping was performed using the PorcineSNP60 BeadChip (Illumina Inc., San Diego, CA, USA) according to the manufacturer\'s SNP Infinium HD assay protocol. In brief, 200 ng of DNA were amplified, fragmented, and hybridized to the PorcineSNP60 BeadChip containing 62,163 locus-specific 50-mers that are covalently linked to beads distributed on the microarray surface. Single-base extension of captured oligos allowed the incorporation of labelled nucleotides that were detected by Illumina iScan, and images were subsequently converted to intensity data. The intensity data were normalized and the cluster position, genotype, and quality score were assigned using the GenomeStudio software (Illumina Inc.). Quality control steps were applied including removing samples with call rates \< 99%. Markers with low minor-allele frequency (\< 5%) were excluded. Markers that strongly deviated from Hardy-Weinberg equilibrium (p \< 0.0001) were also filtered out. The average call rate for all samples was 99.8% ± 0.2. All markers on the PorcineSNP60 BeadChip were mapped to the porcine reference genome, Sscrofa 10.2.

Single SNPs GWAS {#sec005}
----------------

Haematological traits were analysed for an association with SNPs using a mixed-model analysis of variance in JMP Genomics (SAS Institute, Cary, NC, USA). Mixed-model analysis tests an association between traits and a single SNPs and simultaneously adjusts for population structure and family relatedness \[[@pone.0159212.ref013]\]. The genetic similarity matrix between individuals was first computed as identity by descent of each pair for the k-matrix. This genome wide relatedness and the slaughter day were used as random effects. For controlling of population stratification, the correlation-selected principal components analysis was used \[[@pone.0159212.ref014], [@pone.0159212.ref015]\]. Significant correlations at a false discovery rate (FDR) of 5% were considered as covariates. Additionally, genotype and gender were used as fixed effects, age and carcass weight were considered as covariates. Significantly associated SNP markers were reported at a threshold of NegLog10 (p-value) \> 5. In order to consider multiple testing issues, a false discovery rate (FDR) was estimated (FDR \< 5% corresponding to NegLog10 (p-value) \> 6).

Bayesian GWAS {#sec006}
-------------

Prior to the analyses, the genotype matrix was processed using fastPHASE (version 1.2) to impute missing genotype information \[[@pone.0159212.ref016]\]. Bayesian models implemented in GenSel software (version 4.55R) were applied to the dataset \[[@pone.0159212.ref017]\]. All analyses were performed using a chain length of 51000 iterations with the first 1000 cycles being discarded as burn-in. An output was created at every 50th iteration. The proportion of SNP that were considered as having no effect in a single iteration was set to π = 0.995. Thus, approximately 240 SNPs were reported in a single iteration of the Markov chain Monte Carlo (MCMC) sampling. Initially, the Bayes C approach was used to estimate additive genetic and residual variance components for each trait. The heritability was calculated as the proportion of the additive genetic variance to the total phenotypic variance. Subsequently, the prior information of variance components was used to run Bayes B models and estimate SNP effects. For haematological traits, fixed effect of gender was considered as class variable in the models. Age and carcass weight were included as covariates. In addition, estimated SNP effects were combined for all markers located in non-overlapping 1-Mb windows and the window contributions to the genetic variance were estimated using the window option implemented in the GenSel software. In total, 2559 1-Mb windows located on autosomes and the X chromosome were included in the analyses. The theoretical proportion of a single window to the genetic variance of a trait was approximately 0.039% (100%/2559) and 1-Mb windows with contributions above 0.5% were reported.

Results {#sec007}
=======

Phenotypic and genotypic measurements {#sec008}
-------------------------------------

591 pigs of commercial German Landrace (DL) were analysed for the following haematological traits: White blood cell count (WBC), Red Blood Cell Count (RBC), Haematocrit level (HCT), Haemoglobin concentration (HGB), Mean Corpuscular Volume (MCV), Mean Corpuscular Haemoglobin (MCH, ratio of HGB to RBC), Mean Corpuscular Haemoglobin Concentration (MCHC, ratio of HGB to HCT), Red Distribution Width (RDW); Platelets (PLT); Mean Platelet Volume (MPV); Plateletcrit (PCT); and Lymphocytes count (LYM). Means of raw data, variance components and heritability estimates generated by the BayesC analyses for the haematological traits are listed in [Table 1](#pone.0159212.t001){ref-type="table"}. Heritability estimates for haematological traits were medium to high (0.17--0.69).

After filtering, 48,909 SNPs were retained for the subsequent GWAS by both single-marker analysis and Bayesian multi-marker approach. For single-marker analysis, a total of 252 SNPs associated with 12 haematological traits were revealed at significance levels of negative log 10 of p value \> 5 (See: [S1 Table](#pone.0159212.s001){ref-type="supplementary-material"}, [Fig 1](#pone.0159212.g001){ref-type="fig"}). The top five markers associated with each trait are shown in [Table 2](#pone.0159212.t002){ref-type="table"} for haematological traits. For the Bayesian multi-marker approach, 1-Mb windows with an explained additive genetic variance of the traits above 0.5% were reported. In total 102 QTL regions were associated with haematological traits that were distributed across the whole genome (See: [S2 Table](#pone.0159212.s002){ref-type="supplementary-material"}, [Fig 2](#pone.0159212.g002){ref-type="fig"}). The regions overlapping between the results of single- (generalized linear model) and multi- (Bayesian approach) marker genome- wide association analyses accounted for 24 out of 102 overlapping QTL regions (See: [S2 Table](#pone.0159212.s002){ref-type="supplementary-material"}). The transcripts located in the overlapping regions, especially those that showed largest QTL effect for each haematological trait are shown in [Table 3](#pone.0159212.t003){ref-type="table"}.

![Manhattan plots displaying the genome-wide association based on single-markers analysis with haematological traits in German Landrace.\
Black lines indicate the significance threshold corresponding to negative log10 (NegLog10)\>5.](pone.0159212.g001){#pone.0159212.g001}

![Manhattan plots displaying the genome-wide association based on the Bayesian multi-marker approach (Bayes B) for haematological traits in German Landrace.\
Horizontal line represents the threshold of 0.05% of additive genetic variance explained by 1-Mb marker windows.](pone.0159212.g002){#pone.0159212.g002}

10.1371/journal.pone.0159212.t002

###### Results of single-marker (generalized linear mixed model) genome-wide association analyses in a commercial German Landrace pig population.

![](pone.0159212.t002){#pone.0159212.t002g}

  Trait   SNP_ID        SSC   position    Candidate genes   Major/minor allele   Variance explained   P-value
  ------- ------------- ----- ----------- ----------------- -------------------- -------------------- ----------
  HCT     ASGA0055625   13    2696249                       A/G                  4.20%                9.99E-07
  HCT     MARC0069568   1     305211691   NUP214            G/A                  3.72%                4.26E-06
  HCT     ASGA0068589   15    1138203                       A/C                  3.64%                5.52E-06
  HCT     ASGA0068559   15    666572                        G/A                  3.48%                8.81E-06
  HCT     ALGA0122657   6     136078566                     C/A                  3.45%                9.63E-06
  HGB     ASGA0106305         67212092                      A/G                  4.43%                5.68E-07
  HGB     MARC0018859   10    13257224    LOC100520091      C/A                  4.00%                2.10E-06
  HGB     ASGA0071068   15    141300399                     G/A                  3.85%                3.22E-06
  HGB     SIRI0000352   15    141355395                     A/G                  3.85%                3.22E-06
  HGB     CASI0009310   4     13581654                      A/G                  3.53%                8.51E-06
  LYM     ALGA0079602   14    78525259                      G/A                  4.26%                9.49E-07
  LYM     ASGA0064978   14    78068318    DDX21             G/A                  4.19%                1.01E-06
  LYM     ALGA0079529   14    77974347    STOX1             A/G                  4.11%                1.30E-06
  LYM     ASGA0004304   1     125555348   LIPC              G/A                  3.86%                2.75E-06
  LYM     H3GA0007030   2     88476158                      G/A                  3.67%                4.87E-06
  MCH     ALGA0004603         153917457                     G/A                  6.90%                3.39E-10
  MCH     ASGA0081192   X     62086511    EFNB1             C/A                  6.57%                9.34E-10
  MCH     H3GA0049198   17    52392791    SERINC3           A/G                  5.30%                4.20E-08
  MCH     ASGA0003713   1     95391090                      A/G                  5.20%                5.81E-08
  MCH     MARC0009397   X     51700353    SMC1A             A/G                  5.06%                8.83E-08
  MCHC    ALGA0116756   16    75218282    GRIA1             G/A                  4.72%                2.58E-07
  MCHC    ALGA0026794   4     100817218   FCRL3             A/G                  3.98%                2.34E-06
  MCHC    ALGA0082915   14    146908519   FANK1             G/A                  3.89%                3.03E-06
  MCHC    M1GA0019565   14    146929488                     G/A                  3.70%                5.27E-06
  MCHC    INRA0040046   13    39012509    CHDH              G/A                  3.66%                5.92E-06
  MCV     H3GA0055482         143472051                     A/G                  5.49%                2.03E-08
  MCV     ALGA0099736   X     48628584                      G/A                  5.30%                3.61E-08
  MCV     MARC0071761   X     48604940                      G/C                  5.30%                3.61E-08
  MCV     H3GA0002563   1     122922363                     A/G                  5.25%                4.12E-08
  MCV     ASGA0081192   X     62086511    EFNB1             C/A                  5.15%                5.62E-08
  MPV     ALGA0066401   12    42685899                      G/A                  5.00%                9.10E-08
  MPV     MARC0044698   12    42662420                      A/G                  4.54%                3.66E-07
  MPV     M1GA0024295         45786519                      G/A                  4.77%                1.09E-06
  MPV     H3GA0051240   18    58034747                      G/A                  4.09%                1.42E-06
  MPV     ASGA0051711   11    77040959    LOC100524825      A/G                  3.80%                3.45E-06
  PCT     M1GA0000623   1     9221985     IGF2R             G/A                  4.40%                6.72E-07
  PCT     ALGA0054690   9     123960077                     A/G                  4.13%                1.50E-06
  PCT     SIRI0000179   15    15594040                      A/G                  4.02%                2.12E-06
  PCT     ALGA0108179   2     65200938    LOC100515528      A/C                  3.97%                2.41E-06
  PCT     DIAS0003568   2     65152586    PKN1              G/A                  3.97%                2.41E-06
  PLT     ASGA0030815   7     5233250     BMP6              A/G                  5.66%                2.18E-08
  PLT     H3GA0048433   17    34347812                      A/G                  4.60%                4.82E-07
  PLT     H3GA0047920   17    13605158                      A/G                  4.48%                6.90E-07
  PLT     H3GA0053642   6     134996322   LOC102162168      G/A                  4.27%                1.27E-06
  PLT     H3GA0055786         195877640                     G/A                  4.19%                1.59E-06
  RBC     ALGA0104402   6     136084448                     A/C                  4.13%                1.14E-06
  RBC     M1GA0001919   1     305953354                     A/C                  3.91%                2.26E-06
  RBC     MARC0069568   1     305211691   NUP214            G/A                  3.89%                2.39E-06
  RBC     ALGA0122657   6     136078566                     C/A                  3.87%                2.57E-06
  RBC     ASGA0055625   13    2696249                       A/G                  3.81%                3.08E-06
  RDW     ALGA0099585   X     38268046                      A/G                  5.59%                1.48E-08
  RDW     ALGA0099588   X     38289148                      G/A                  5.38%                2.83E-08
  RDW     ALGA0096935   18    8952443     ESYT2             G/A                  5.00%                8.85E-08
  RDW     H3GA0055482         143472051                     A/G                  4.60%                3.02E-07
  RDW     DRGA0009770   9     124492658   TPK1              A/G                  4.33%                6.80E-07
  WBC     H3GA0020550   7     30832008                      A/G                  4.10%                1.60E-06
  WBC     ALGA0095413   17    52208129    HNF4A             G/A                  3.92%                2.74E-06
  WBC     ASGA0091117   17    51942244    TOX2              A/G                  3.80%                3.98E-06
  WBC     ASGA0090286   17    51967501    TOX2              A/G                  3.45%                1.14E-05
  WBC     MARC0043068   3     65094505                      A/G                  3.27%                1.91E-05

table shows the top 5 markers for each of the 12 haematological traits

10.1371/journal.pone.0159212.t003

###### Results of multi- (Bayesian approach) marker genome-wide association analysis in a commercial German Landrace pig population.
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  Trait   SSC   start (Mb)   end (Mb)   %Var   \#SNPs   Gene located within region and/or overlap with single gene GWAS
  ------- ----- ------------ ---------- ------ -------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  HCT     8     139          139.9      1.82   34       FAM13A, HERC3, PYURF
  HCT     15    0            1          0.62   27       LOC100739056, NEB
  HGB     5     4.1          4.9        1.54   24       PMM1, SCL25A17
  HGB     16    5            5.9        1.62   25       MARCH11, FBXL7
  LYM     14    77           78         0.55   16       STOX1[\*](#t003fn002){ref-type="table-fn"}
  LYM     14    78           79         2.16   28       DDX21[\*](#t003fn002){ref-type="table-fn"}
  LYM     X     44.1         45         1.01   14       KDM6A
  LYM     X     45           46         1.06   19       miR-221, miR-222
  MCH     17    51           52         1.33   29       L3MBTL1[\*](#t003fn002){ref-type="table-fn"}
  MCH     17    52           53         1.15   24       TOX2[\*](#t003fn002){ref-type="table-fn"}, MYBL2[\*](#t003fn002){ref-type="table-fn"}, SERINC3[\*](#t003fn002){ref-type="table-fn"}, LOC102159476[\*](#t003fn002){ref-type="table-fn"}
  MCH     X     2            2.8        2.72   15       NLGN4X
  MCHC    7     40           41         2.53   30       KANK4
  MCHC    15    140          140.9      3.21   28       EIF2B1
  MCV     1     259          259.9      1.55   15       TLE4
  MCV     13    140          140.9      1.7    15       OPA1,TMEM44
  MCV     X     2            2.8        1.57   15       NLGN4X
  MCV     X     62.1         62.7       1.32   4        EFNB1[\*](#t003fn002){ref-type="table-fn"}
  MPV     1     284          285        1.14   27       SNX30
  MPV     12    62           63         0.64   30       CENPV[\*](#t003fn002){ref-type="table-fn"}
  MPV     18    0            1          1.23   19       
  MPV     18    43           43.9       0.67   21       BMPER[\*](#t003fn002){ref-type="table-fn"}, LOC102163798[\*](#t003fn002){ref-type="table-fn"}
  PCT     1     9            10         5.13   29       IGF2R[\*](#t003fn002){ref-type="table-fn"}, MAS1,PARK2
  PCT     2     69.1         69.8       0.79   8        ZGLP1[\*](#t003fn002){ref-type="table-fn"}, ICAM3, CDC37
  PCT     9     0            1          2.23   39       
  PLT     2     69.1         69.8       2.3    8        ZGLP1[\*](#t003fn002){ref-type="table-fn"}
  PLT     7     5            6          1.14   30       BMP6[\*](#t003fn002){ref-type="table-fn"}, BLOC1S5
  RBC     1     305.1        306        0.7    39       NUP214[\*](#t003fn002){ref-type="table-fn"}
  RBC     6     136          137        0.53   17       RAVER2[\*](#t003fn002){ref-type="table-fn"}
  RBC     16    5            5.9        1.36   25       MARCH11, C7H14orf2
  RDW     1     259          259.9      2.92   15       TLE4
  RDW     7     108.1        109        2.13   15       LOC100737221
  RDW     9     124.1        124.6      2.92   13       TPK1[\*](#t003fn002){ref-type="table-fn"}
  RDW     13    140          140.9      4.74   15       OPA1,TMEM44, LOC100627758
  RDW     X     2            2.8        3.16   15       NLGN4X
  WBC     14    28           29         2.21   29       TMEM132C
  WBC     17    51           52         1.01   29       TOX2[\*](#t003fn002){ref-type="table-fn"}

table shows QTL regions that explain the highest proportion of the genetic variance or overlap with single-marker analysis for haematological traits.

\*the candidate gene which overlap between single- (generalized linear mixed model) and multi- (Bayesian approach) marker genome- wide association analysis

White blood cell count and Lymphocytes count {#sec009}
--------------------------------------------

Regarding the analysis of GWAS for WBC, only 3 SNPs located on chromosomes 7 and 17 reached the threshold levels of 5% FDR. The most significant markers associated with WBC located on SSC7 (30.8 Mb; H3GA0020550). The other 2 SNPs (ALGA0095413 and ASGA0091117) located on SSC17 (51.9--52.2 Mb) in the vicinity of the TOX high mobility group box family member 2 (*TOX2)* gene locus (P = 1.6x10^-6^ and P = 2.7x10^-6^) as shown in Manhattan plots of WBC ([Fig 1](#pone.0159212.g001){ref-type="fig"}). Bayesian multi-marker approach detected the region that explained 2.2% of the additive genetic variance for WBC at 28--29 Mb on SSC14 ([Fig 2](#pone.0159212.g002){ref-type="fig"}). The overlapping region with single-marker analysis was also found on SSC17 (51--52 Mb) and explained 1.01% of the additive genetic variance for WBC. The top 4 LYM associated SNPs mapped on SSC14 (77.9--78.5 Mb) in DEAD-box helicase 21 (*DDX21)* and storkhead box 1 (*STOX1)* and on SSC1 in lipase C, hepatic type (*LIPC)* ([Table 2](#pone.0159212.t002){ref-type="table"} and [Fig 1](#pone.0159212.g001){ref-type="fig"}). It is noteworthy that at the same region on SSC14, QTLs for LYM were identified by Bayesian method, which explained 2.16% of the additive genetic variance ([Fig 2](#pone.0159212.g002){ref-type="fig"}). The other two overlapping regions on SSCX were detected by the Bayesian analysis and by the single-marker analysis for an association with LYM. These regions contained the interesting transcripts of lysine demethylase 6A (*KDM6A)* and micro RNA (miR-221 and miR-222) ([Table 3](#pone.0159212.t003){ref-type="table"}).

Red blood cell traits {#sec010}
---------------------

We performed GWAS for the following seven erythrocyte-related traits: RBC, HCT, HGB, MCV, MCH, MCHC and RDW. The single-marker approach revealed a number of genetic loci that were significantly associated with RBC (9 loci), HCT (1 loci), HGB (4 loci), MCV (98 loci), MCH (78 loci), MCHC (5 loci) and RDW (27 loci) at significance thresholds of FDR \< 5% and NegLog10 (p-value) \> 5. The detailed information is shown in additional file 1: [S1 Table](#pone.0159212.s001){ref-type="supplementary-material"}. In addition, the corresponding Manhattan plots are shown in [Fig 1](#pone.0159212.g001){ref-type="fig"} and the top 5 most significant associations are listed in [Table 2](#pone.0159212.t002){ref-type="table"}.

Interestingly, overlaying the results from both analysis methods consistently discerned RBC associated regions located on SSC1 (305.1--305.2 Mb) physically linked to nucleoporin 214 (*NUP214)*, and on SSC6 (136 Mb) in ribonucleoprotein, PTB binding 2 (*RAVER2)*. The QTL region for RBC with the largest effect was found on SSC16 (5--5.9 Mb) explaining 1.36% of the additive genetic variance ([Fig 2](#pone.0159212.g002){ref-type="fig"}). This region was annotated with the transcript of membrane associated ring-CH-type finger 11 (*MARCH11)* and *C7H14orf2*. The SNPs on *NUP214* also associated with HCT (p = 4.2x10^-6^). A region with the largest QTL effect for HCT accounting for 1.82% of the additive genetic variance encompassed the potential candidate genes family with sequence similarity 13 member A (*FAM13A)*, HECT and RLD domain containing E3 ubiquitin protein ligase 3 (*HERC3)* and PIGY upstream reading frame (*PYURF)*. The results also showed some discrepancies between the two GWAS analysis methods such as HGB of which most significant single SNPs were located on SSC15 (141.3 Mb), while multi-marker analysis detected significant loci on SSC5 (4.1--4.9 Mb) and SSC16 (5.0--5.9 Mb).

Most prominent regions revealed from single-marker analyses with MCV and MCH were located on SSCX (46--63 Mb), peaking in the ephrin B1 (*EFNB1)* gene (p = 9.3x10^-10^ for MCH and p = 5.6x10^-8^ for MCV), and on SSC1 (90--105 Mb), covering interesting genes like inhibitor of Bruton tyrosine kinase (*IBTK)* and CD109 molecule (*CD109)*. On SSC17 (50.9--52.9 Mb) the region spanning the l(3)mbt-like 1 (*L3MBTL1)*- MYB proto-oncogene like 2 (*MYBL2)*-*TOX2*- serine incorporator 3 (*SERINC3)* locus showed effect on MCH as revealed by both single- and multi-marker analyses. For MCV a wide QTL region was identified on SSC2 including 4 significantly associated SNP and further supported by two windows exceeding the threshold in Bayesian GWAS (See: [S2 Table](#pone.0159212.s002){ref-type="supplementary-material"}).

Eleven SNPs significantly associated with MCV, MCH and RDW and located on SSCX (49.5--63.2 Mb), covering the region of *LOC100521307*, Cdc42 guanine nucleotide exchange factor 9 (*ARHGEF9)* and ectodysplasin-A (*EDA)*. By means of multi-marker analysis, a region on SSCX (2--2.8 Mb) explained the most of variance for MCV (1.57%), MCH (2.72%) and RDW (3.16%); the locus was physically linked with the transcript of neuroligin 4, X-linked (*NLGN4X)* ([Table 3](#pone.0159212.t003){ref-type="table"}). Furthermore, we identified single-markers on SSC16 (glutamate ionotropic receptor AMPA type subunit 1(*GRIA1*), SSC4 (Fc receptor like 3 (*FCRL3*) and SSC14 (fibronectin type III and ankyrin repeat domains 1 (*FANK1*) associated with MCHC. In contrast, multi-marker analysis of MCHC revealed QTL on SSC7 (40--41 Mb) and SSC15 (140.0--140.9 Mb) which cover KN motif and ankyrin repeat domains 4 (*KANK4)* and eukaryotic translation initiation factor 2B subunit alpha (*EIF2B1)*.

Platelet traits {#sec011}
---------------

We performed GWAS for three platelet traits: PLT, MPV and PCT. In total, we found 29 PLT loci, 16 MPV loci and 21 PCT loci (See: [S1 Table](#pone.0159212.s001){ref-type="supplementary-material"} and [Fig 1](#pone.0159212.g001){ref-type="fig"}) for single-marker GWAS. The most significant SNPs associated with MPV were MARC0044698 and ALGA0066401 of SSC12 (42.6 Mb) with p = 3.7x10^-7^ and p = 9.1x10^-8^. By multi-marker analysis, QTL with the largest effect identified was on SSC18 at 0--1 Mb, follow by SSC1 at 284--285 Mb which explained 1.23% and 1.14% of the additive genetic variance of MPV, respectively. The SNP ASGA0030815 on bone morphogenetic protein 6 (*BMP6)* (SSC7) and MIGA0002922 on zinc finger, GATA-like protein 1 (*ZGLP1)* (SSC2) were associated with both PLT and PCT. Moreover, the region on SSC2 (69.1--69.8 Mb) was also confirmed by multi-marker analysis ([Table 3](#pone.0159212.t003){ref-type="table"}). It should be noted that two loci significantly associated with PCT hosted candidate genes with biologically plausible functions. The M1GA0000623 SNP within the insulin like growth factor 2 receptor (*IGF2R)* gene (SSC1) was highly associated with PCT with p = 6.7x10^-7^; this region (SSC1, 9--10 Mb) was also confirmed by the multi-marker analysis with the greatest effect that explained 5.13% of the additive genetic variance and hosting 2 interesting transcripts *IGF2R* and MAS1 proto-oncogene (*MAS1)* ([Table 3](#pone.0159212.t003){ref-type="table"}).

Discussion {#sec012}
==========

The proportion of phenotypic variance explained by markers is considered as a measure of heritability and therefore indicates whether these traits are heritable. Heritability estimates for haematological traits in our study were shown to be moderate for WBC (0.23) which is in line with previous studies in Large White and Yorkshire pigs \[[@pone.0159212.ref018], [@pone.0159212.ref019]\]. Our findings showed that erythrocyte-related traits RBC, HCT, HGB, and RDW were moderately heritable (0.34 to 0.48) compared to MCV, MCH and MCHC which were highly heritable (0.67--0.69). However, in another genetic background RBC and HCT were highly heritable (0.56--0.62) compared to MCV and MCH which were moderately heritable (0.37--0.47), as reported by Mpetile and colleague \[[@pone.0159212.ref019]\]. The discrepancies of heritability estimation could be due to genetic differences in the breeds studied and the age of the animals when the phenotypic variance was measured.

In total, the single-marker GWAS by GLM analysis revealed 252 SNPs associated with 12 haematological traits at significance levels of 5% FDR, whereas the Bayesian approach detected altogether 102 QTL regions across the genome for 12 haematological traits using a 1- Mb window and the genetic variance above 0.5%. The multi-markers method was challenged to avoid false positives and overestimation of QTL effects derived from single-SNP analysis; accordingly, Bayesian approaches involving SNP-windows to reflect QTL have been applied in many studies before \[[@pone.0159212.ref020]--[@pone.0159212.ref022]\]. To take advantage of the Bayesian approach and to enhance the power of finding potential candidate genes, we combined the results from both methods by overlaying the derived QTL.The integration of both methods resulted in 24 overlapping QTL regions. For lymphocyte count, two overlapping regions from both methods located on SSCX (44.1--46.0 Mb) at *KDM6A*, miR-221 and miR-222, and SSC14 (77--79 Mb) at *STOX1* and *DDX21*. *KDM6A* (histone 3 lysine 27 demethylase UTX) was identified as a novel regulator for haematopoietic cell migration by using haematopoietic stem and progenitor cell \[[@pone.0159212.ref023]\]. Consistency of results between both methods was also found for WBC on SSC17 (51--52 Mb) at *TOX2*. *TOX2* is a transcription factor belonging to the TOX family that shares a highly conserved high mobility group DNA-binding domain with the other TOX members. As recently reported, *TOX2* regulates human natural killer cell development by controlling T-BET expression \[[@pone.0159212.ref024]\]. Recently, a study demonstrated that transcriptional regulator TOX is required for the in vivo differentiation of common lymphoid progenitors into innate lymphoid cells \[[@pone.0159212.ref025]\]. All together there is growing evidence promoting *TOX2* as a candidate gene for WBC counts.

QTL for MCH and MCV were reported in many pig chromosomes in particular on SSC2 at 55--60 Mb \[[@pone.0159212.ref011]\] and SSC8 at 42--73 Mb which covers the KIT gene \[[@pone.0159212.ref009], [@pone.0159212.ref010], [@pone.0159212.ref026]\]. KIT regulatory mutations are responsible for the dominant white phenotype in pigs \[[@pone.0159212.ref027]\] and have profound pleiotropic effects on peripheral blood cell measures in Western commercial crossbred pigs and experimental crosses \[[@pone.0159212.ref006], [@pone.0159212.ref028], [@pone.0159212.ref029]\]. Inconsistently, others have not found any significant association between the KIT mutations and haematological parameters \[[@pone.0159212.ref030], [@pone.0159212.ref031]\]. Also, in our study, no significant associations with red blood cell traits were detected for both of these regions, in particular not of the KIT region. Landrace pigs have solid white coat color phenotypes and are usually homozygous for the dominant white allele (I) at the KIT gene. Thus there is not QTL segregating; consequently there are no significant SNPs found around the KIT region.

In this study, a region on SSC8 at 128 Mb was found significantly associated with MCV by means of single-marker analysis. Interestingly, Bayesian approaches persistently detected an associated effect for MCV, MCH, and RDW on SSC1, SSC13 and SSCX which constitute some plausible candidate genes contributing to red blood cell traits via haematopoietic mechanisms including *EFNB1*, *TLE4* and *OPA1*. In particular, identified regions on SSCX at 2.0--2.8 Mb and 62.1--62.7 Mb include *NLGN4X* and *EFNB1* as interesting candidate genes. *NLGN4X* encodes a protein which belongs to a family of neuronal cell surface and causal factors for monogenic autism as well as directly impacts neurodevelopmental processes during the formation of neurons and their connections \[[@pone.0159212.ref032], [@pone.0159212.ref033]\]. *EFNB1* encodes a membrane protein that acts as a ligand for Ephrin receptor tyrosine kinases and thus play a potential role in modulating blood pressure \[[@pone.0159212.ref034]\]. *EFNB1* was detected in leukaemia cell lines and bone marrow and was shown to be involved in normal haematopoietic development and tumorigenesis \[[@pone.0159212.ref035], [@pone.0159212.ref036]\]. The other candidate gene located on SSC1 which involved in the complex processes of haematopoiesis was *TLE4*. The TLE family of genes is a group of highly conserved transcriptional corepressors that are involved in myeloid cell proliferation and survival \[[@pone.0159212.ref037]\]. Tle4 knockout mice exhibit leukocytopenia, B cell lymphopenia, and significant reductions in haematopoietic stem and progenitor cells \[[@pone.0159212.ref038]\]. Another plausible candidate locus contributing to red blood cell traits via energy metabolism of erythropoiesis was OPA1 located on SSC13 (140--140.9 Mb).This locus explains 1.7 and 4.7% of the additive genetic variance for MCV and RDW. Erythropoiesis is highly dependent of mitochondrial metabolism through multiple ways \[[@pone.0159212.ref039]\]. The *OPA1* gene encodes a dynamin-like mitochondrial GTPase OPA1and plays a significant role in mitochondrial structure, maintenance and fusion. In addition, OPA1 --is involved in the regulation of energetic metabolism and cell death, which underscores its multiple physiological roles \[[@pone.0159212.ref040]\]. Recently, it was reported that when erythropoietic cells are copper deprived, *MFN2* and *OPA1* become up-regulated and functional to promote fusion \[[@pone.0159212.ref041]\].

In a previous study, the QTLs for RBC were mapped on the end of SSC1 \[[@pone.0159212.ref009]\]. Regarding the present study, one of common candidate genes in SSC1 (305.1--306 Mb) that associated with HCT and RBC, was *NUP214*. The gene is a member of the FG-repeat-containing nucleoporins and known to be fused with the DEK gene on chromosome 6 in a t(6,9)-translocation associated with acute myeloid leukemia and myelodysplastic syndrome \[[@pone.0159212.ref042]\].

The highly significant SNPs and regions, that both approaches detected s to be associated with platelet traits (PCT), were physically linked to the *IGF2R* gene (SSC1, 9--10 Mb). The IGFs have an important role in physiologic and neoplastic processes as well as normal and malignant development of the haematopoietic system \[[@pone.0159212.ref043], [@pone.0159212.ref044]\]. Recently, it was reported that deletion of the insulin receptor in murine resulted in an increases platelets count and volume, and blocked the action of insulin on platelet signalling and function \[[@pone.0159212.ref045]\]. *ZGLP1* (zinc finger, GATA-like protein 1) is a strong positional candidate gene for both PCT and PLT but there is still limited knowledge about the function of this gene. GWAS of PLT further revealed the *BMP6* gene which is the key endogenous regulator of hepcidin, an iron homeostasis gene \[[@pone.0159212.ref046]\]. In this context, it was also reported that iron deficiency increases megakaryopoietic differentiation and alters platelet phenotype \[[@pone.0159212.ref047]\].

Conclusions {#sec013}
===========

In summary, our study provides insights into the genetic architecture of haematological traits and opens new opportunities to the application of haematological parameters as a monitoring indicator for health and infection in pigs. Taking the advantages of Bayesian GWAS approach, combined with a GLM single-marker approach, we were able to provide a list of promising QTL regions and plausible candidate genes that carry common genetic variants associated with RBC, WBC, and platelet phenotypes. Further validation and identification of the causal mutations are necessary. This study provides an additional step towards the understanding of the molecular basis of blood cell phenotypes and could be used as a model for many diseases which might be simpler for blood cell traits rather than most other complex phenotype.

Supporting Information {#sec014}
======================

###### Results of single-marker genome-wide association analyses for 12 haematological traits.

List of significantly associated SNP markers at NegLog10 (p-value) \> 5 obtained by single-marker analysis. Haematological traits, marker name, chromosome, position according to Pig Genome Annotation 10.2, major/minor allele, % variance explained, p-value (NegLog10), positional candidate gene.

(XLSX)

###### 

Click here for additional data file.

###### Results of multi-marker genome-wide association analyses for 12 haematological traits.

List of 1-Mb windows with % variance explained \> 0.5%. Haematological traits, chromosome, position of start and end of window according to Pig Genome Annotation 10.2, % of the additive genetic variation explained by the QTL regions associated with the traits, number of SNPs in the QTL regions, regions overlapping between the results of single- (generalized linear model) and multi- (Bayesian approach) marker genome- wide association analyses.

(XLSX)

###### 

Click here for additional data file.
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